Megan Mcshane, OTR/L | |
7395 W Eastman Pl, Lakewood, CO 80227-5006 | |
(303) 730-8000 | |
Not Available |
Full Name | Megan Mcshane |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 7395 W Eastman Pl, Lakewood, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972996528 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Megan Mcshane, OTR/L 1001 S Dahlia St, Apt 314, Glendale, CO 80246-8204 Ph: (330) 607-8773 | Megan Mcshane, OTR/L 7395 W Eastman Pl, Lakewood, CO 80227-5006 Ph: (303) 730-8000 |
News Archive
In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.
Bridging integrator 1, known as BIN1, is the second most common risk factor for late-onset Alzheimer's disease, according to genome-wide studies of genetic variants. Yet, scientists know little about what this protein does in the brain.
While the American Thoracic Society appreciates that the FDA took action on certain flavored cartridge-based vaping products, it is disappointed that the Administration chose to not follow through on its September 2019 promise to clear the market of all flavored electronic nicotine delivery projects.
Twelve national organizations representing all areas of the health sector, joined by the David Suzuki Foundation, have produced a joint statement spelling out a new commitment to creating an environmentally responsible health sector.
› Verified 7 days ago